Cargando…

SYSTEMIC TRIPLE THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER (MHSPC)

For many years, androgen deprivation therapy (ADT) as monotherapy has been the gold standard for metastatic hormone-sensitive prostate cancer (mHSPC) treatment. Several studies have been published within the last decade demonstrating a significant survival advantage resulting from combining the trea...

Descripción completa

Detalles Bibliográficos
Autor principal:	Omrčen, Tomislav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sestre Milosrdnice University Hospital and Institute of Clinical Medical Research, Vinogradska cesta c. 29 Zagreb 2022
Materias:	Professional Papers
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10022414/ https://www.ncbi.nlm.nih.gov/pubmed/36938560 http://dx.doi.org/10.20471/acc.2022.61.s3.12

Ejemplares similares

WHO SHOULD RECEIVE NOVEL HORMONAL THERAPY WITH ANDROGEN DEPRIVATION THERAPY IN METASTATIC HORMONE SENSITIVE PROSTATE CANCER?
por: Omrčen, Tomislav
Publicado: (2019)

Systemic Triple Therapy in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Ready for Prime Time or Still to Be Explored?
por: Thomas, Christian, et al.
Publicado: (2021)

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
por: Ng, Kenrick, et al.
Publicado: (2020)

Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
por: Gould, A., et al.
Publicado: (2023)

WHICH PATIENTS WILL BENEFIT MOST FROM DOCETAXEL ADDITION TO ANDROGEN DEPRIVATION THERAPY (ADT) IN METASTATIC CASTRATE-SENSITIVE PROSTATE CANCER (MCSPC)?
por: Gamulin, Marija, et al.
Publicado: (2019)

Estimating utilities/disutilities for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) and treatment-related adverse events
por: Hall, F., et al.
Publicado: (2019)

Multigene Profiling of Circulating Tumor Cells (CTCs) for Prognostic Assessment in Treatment-Naïve Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
por: Reichert, Zachery R., et al.
Publicado: (2021)

IS TESTOSTERONE PROGNOSTIC IN PROSTATE CANCER TREATMENT? THE UROLOGICAL STANDPOINT.
por: Sorić, Tomislav, et al.
Publicado: (2019)

(225)Ac-PSMA-617 radioligand therapy of de novo metastatic hormone-sensitive prostate carcinoma (mHSPC): preliminary clinical findings
por: Sathekge, Mike, et al.
Publicado: (2023)

THE PROSTATE CENTER: MULTIDISCIPLINARITY, ORGANIZATION OF DIAGNOSTIC WORK-UP AND TREATMENT OF PROSTATE CANCER
por: Kuliš, Tomislav, et al.
Publicado: (2019)

Qualitative and Quantitative Assessment of Patient and Carer Experience of Chemotherapy (Docetaxel) in Combination with Androgen Deprivation Therapy (ADT) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
por: Ito, Tetsuro, et al.
Publicado: (2018)

CHALLENGES IN MANIPULATING IMMUNE SYSTEM TO TREAT PROSTATE CANCER
por: Šamija, Ivan, et al.
Publicado: (2019)

SURGICAL TREATMENT OF HIGH-RISK PROSTATIC CARCINOMA AND OLIGOMETASTATIC DISEASE
por: Mokos, Ivica, et al.
Publicado: (2019)

EFFECT OF GROWTH HORMONE THERAPY IN CHILDREN WITH PRADER-WILLI SYNDROME – OUR FIRST EXPERIENCES
por: Stipančić, Gordana, et al.
Publicado: (2018)

THE ROLE OF LYMPHADENECTOMY IN PROSTATE CANCER PATIENTS
por: Markić, Dean, et al.
Publicado: (2019)

GENOMICS OF PROSTATE CANCER: CLINICAL UTILITY AND CHALLENGES
por: Šamija, Ivan, et al.
Publicado: (2022)

MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM
por: Murgić, Jure, et al.
Publicado: (2022)

ROLE OF ANDROGEN RECEPTOR-TARGETED AGENTS IN LOCALIZED PROSTATE CANCER
por: Murgić, Jure, et al.
Publicado: (2022)

RADIOTHERAPY OF PROSTATE CANCER: PRIMARY RADIOTHERAPY AND RADIOTHERAPY IN DISEASE RELAPSE
por: Antunac, Katarina
Publicado: (2019)

CURRENT ROLE OF MAGNETIC RESONANCE IMAGING IN THE SCREENING, DIAGNOSIS, AND TREATMENT OF PROSTATE CANCER
por: Nikles, Sven, et al.
Publicado: (2022)

PROSTATE CANCER DIAGNOSIS IN 2019 - CHANGES IN EUROPEAN GUIDELINES AND IMPACT ON DAILY PRACTICE
por: Tomašković, Igor, et al.
Publicado: (2019)

Elective Central Compartment Lymph Node Dissection Does not Increase the Risk of Postoperative Hypoparathyroidism in Patients Treated for Differentiated Thyroid Cancer
por: Stubljar, Boris, et al.
Publicado: (2020)

Qualitative Approach and Treatment of Patients with Prostate Cancer in Cantonal Hospital Bihac During Two Years Period
por: Kardasevic, Amel, et al.
Publicado: (2014)

Symmetrical Fibrous Hyperplasia of the Palate
por: Katanec, Tomislav, et al.
Publicado: (2021)

CHARACTERISTICS OF CHRONIC RHINOSINUSITIS PHENOTYPES IN PATIENTS UNDERGOING FUNCTIONAL ENDOSCOPIC SINUS SURGERY: AN OBSERVATIONAL COHORT RETROSPECTIVE STUDY
por: Radetić, Martina, et al.
Publicado: (2022)

EVAULATION OF BLINK REFLEX BETWEEN PATIENTS WITH IDIOPATHIC TRIGEMINAL NEURALGIA AND HEALTHY VOLUNTEERS
por: Badel, Tomislav, et al.
Publicado: (2022)

INADEQUACY OF VITAMIN K ANTAGONIST USE IN PATIENTS WITH ATRIAL FIBRILLATION – OVERVIEW OF EVERYDAY CLINICAL PRACTICE AT THE MERKUR UNIVERSITY HOSPITAL IN ZAGREB, CROATIA
por: Stipinović, Mario, et al.
Publicado: (2019)

PELVIC REHABILITATION FOR URINARY INCONTINENCE AFTER RADICAL PROSTATECTOMY
por: Hudolin, Tvrtko, et al.
Publicado: (2022)

OROFACIAL PAIN – DIAGNOSTIC AND THERAPEUTIC CHALLENGES
por: Badel, Tomislav, et al.
Publicado: (2019)

Future directions in systemic treatment of metastatic hormone-sensitive prostate cancer
por: Chen, Kenneth, et al.
Publicado: (2022)

ANESTHESIA FOR ROBOT-ASSISTED RADICAL PROSTATECTOMY - A CHALLENGE FOR ANAESTHESIOLOGIST
por: Bačak Kocman, Iva, et al.
Publicado: (2022)

CARDIOVASCULAR DISEASES AND ANDROGEN DEPRIVATION THERAPY
por: Boban, Marko
Publicado: (2019)

Pulmonary Hypertension – New Trends of Diagnostic and Therapy
por: Pesto, Senad, et al.
Publicado: (2016)

NUTRITIONAL THERAPY IN THE TREATMENT OF ACUTE CORROSIVE INTOXICATION IN ADULTS
por: Chibishev, Andon, et al.
Publicado: (2016)

SPINAL ANAESTHESIA-INDUCED HYPOTENSION IN OBSTETRICS: PREVENTION AND THERAPY
por: Šklebar, Ivan, et al.
Publicado: (2019)

Needs Assessment of Pathologists Using Telepathology Systems
por: Gohari, Sadrieh Hajesmaeel, et al.
Publicado: (2016)

Reforms and Challenges of Post-conflict Kosovo Health System
por: Mustafa, Mybera, et al.
Publicado: (2014)

THE PREVALENCE OF ONYCHOMYCOSIS IN THE ZAGREB AREA – THE ROLE OF SABOURAUD AGAR WITHOUT CYCLOHEXIMIDE IN DIAGNOSIS AND THERAPY
por: Mendek, Sanja, et al.
Publicado: (2018)

Suggested Minimum Data Set for Speech Therapy Centers Affiliated to Tabriz University of Medical Sciences
por: Damanabi, Shahla, et al.
Publicado: (2015)

Bosnia and Herzegovina Healthcare System Preparedness for Pandemic Influenza as of 2010
por: Begic, Almir, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_cehrsvl167jh7u2b33u006g9up